Uppsala in Last Preclinical Stage for New CAR T-cell Product for Glioblastoma
News
Researchers at Uppsala University, in Sweden, in collaboration with the SciLifeLab Drug Discovery and Development Platform, have taken “a large step forward” in developing a potential CAR T-cell therapy for ... Read more